29 April 2022
A Strong Start – Continued Confidence In The Full Year…
Outlook and guidance is expected to meet the details outlined in the 2021 Annual Report…
28 April 2022
Sustained outperformance in UK with strong current trading momentum; rapid estate growth in Germany; dividend restored…
Strong first quarter performance despite volatile macroeconomic environment…
Ultomiris approved in the US for adults with generalised myasthenia gravis…
Strong Execution in Challenging Conditions…
Smith & Nephew First Quarter 2022 Trading Update…
DS Smith Plc (“DS Smith”) today issues a pre-close trading update in respect of the year ending 30 April 2022….